Skip to main content
. 2021 Oct 19;59(11):e00955-21. doi: 10.1128/JCM.00955-21

TABLE 1.

Summary of chart review patients

Pretest EORTC category No. of:
No. (%) positive by:
Culture vs PCR P valueb
Unique patientsa Patients with pretest antifungal exposure Paired specimens Culture PCR
All 52 43 54 29 (53.7) 36 (66.7) 0.238
Proven IFI 28 23 28 22 (78.6) 25 (89.3) 0.844
Probable IFI 9 7 10 5 (50.0) 7 (70.0) 0.726
Possible IFI 11 11 11 0 (0.0) 1 (9.1) NDd
Not applicablec 5 1 5 2 (40.0) 3 (60.0) ND
a

One patient had parallel PCR and culture performed three times with >3 weeks between each sampling, and each encounter was included as a single unique patient for overall counts, but testing was counted twice as “probable” and once as “proven” IFI based on chart review.

b

Fisher’s exact test.

c

One patient to whom EORTC criteria were not applicable had HIV and a CD4 count of 14 cells/μl, and pretest amphotericin B had a true positive detection of A. fumigatus by PCR only; all other results for patients in this category were clinically thought to reflect bystanders/colonizers.

d

ND, not determined.